Author: Hiren Patel

When Is The Right Time To Get A Vasectomy?

A vasectomy may seem like a permanent fix to most men as it shuts the door on having any or more children. The truth is, that is not the whole story. Half a million men decide to have a vasectomy each year in the US. The decision begins with when is the right time to get a vasectomy and more importantly, is it right for you?

Continue reading “When Is The Right Time To Get A Vasectomy?”

Reasons You May Be Getting Recurring UTIs

A UTI is an infection in any part of your urinary tract. Having one UTI is painful enough, but having them come back can be quite frustrating. If you get three or more of these infections within a year, this recurrence is known as chronic. However, the reasons you may be getting recurring UTIs might surprise you. Time to find out why and what to do about it.

Continue reading “Reasons You May Be Getting Recurring UTIs”

The Link Between Smoking And Bladder Cancer

Smoking is an “equal opportunity offender.” It is just as deadly for women as it is for men when it comes to bladder cancer. Regardless of gender, one of the most important risk factors for developing bladder cancer is smoking. Let’s learn more specifics about the link between smoking and bladder cancer.

Continue reading “The Link Between Smoking And Bladder Cancer”

When Do Men Need Low Testosterone Treatment?

You have probably seen any number of ads on the television and online about low T. They seem to indicate that this is a growing national problem and all men should begin taking medication to correct their testosterone deficiency and become more “manly men.” It might be time to slow this growing snowball down the mountain, and look carefully to evaluate when do men need testosterone treatment?

If you are looking to take action and find a solution to your low testosterone, please contact McIver Clinic today to schedule an appointment. Our board-certified urologist will help diagnose your symptoms and discover the best treatment option for you and your lifestyle. You can reach our office at (904) 355-6583 or by using our secure form.

Continue reading “When Do Men Need Low Testosterone Treatment?”

NeoTract Designates Dr. C. Shawn West as UroLift® Center of Excellence

Designation Recognizes Dr. West’s Commitment to Exemplary Care, Extensive UroLift® System Experience

PLEASANTON, CALIF. (PRWEB) JUNE 17, 2020

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that C. Shawn West, M.D., McIver Clinic in Jacksonville, FL, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. West has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“We are proud to name Dr. C. Shawn West as a UroLift Center of Excellence and provider of care for men with enlarged prostate symptoms using the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “The UroLift System is a safe and effective treatment that allow physicians to treat men in-office under local anesthesia, so they can experience lasting symptom relief within days after receiving treatment.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated: Jake Elguicze, 610.948.2836
Treasurer and Vice President, Investor Relations

Media:
Nicole Osmer, 650.454.0504
nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction
1. Roehrborn, J Urology 2013 LIFT Study
2. McVary, J Sex Med 2016

MAC00968-01 Rev A